2026. Repurposing of Thalidomide as a Potential Therapeutic Agent for Idiopathic Pulmonary Fibrosis: An In Silico Molecular Docking Study. International Journal of Research in Pharmaceutical Sciences and Technology. 9, 3 (Aug. 2026). DOI:https://doi.org/10.33974/st7x9s50.